From Geoffrey Sheldon, VP, Brand Planning Director, Palio
One of the biggest factors in ensuring a successful launch of a new prescription drug lies in a marketer’s ability to generate pre-launch buzz and brand name awareness. Unfortunately, this is often easier said than done, due to restrictions by DDMAC on what can and can’t be said about products in development.
So what are the allowable forms of pre-launch promotion, and what can you do as a marketer to generate that critical pre-launch brand awareness while staying compliant with DDMAC’s guidance on prelaunch promotion?
If you need a quick answer to this question why not take a minute out of your day, and read “The 60-Second Guide to Understanding DDMAC’s Guidance on Prelaunch Communications”
As the title implies; it’s a quick, easy, yet informative read.
No Slideshare account?! Download it here – The 60-Second Guide to Understanding DDMAC’s Guidance on Prelaunch Communication
Palio is a full-spectrum global pharmaceutical and consumer advertising, marketing, and communications agency that excels in brand creation and specializes in brand strategy, product launches, global marketing, and digital and integrated media.